EDESA BIOTECH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.45 USD | +2.06% |
|
-0.67% | -2.63% |
| Mar. 05 | Top Premarket Gainers | MT |
| Feb. 09 | Edesa Biotech, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Chart calendar Edesa Biotech, Inc.
40f2ca659f6a7355.T_pQ4KqGvBXUcfmL-mJvCusL2mgf-XJW0EsZn_oyFCs.G5M-p53CxSGfArjRwwg_Ut49s0VcqV8Bhi8qqLNCbBoFniDSyMyIV-Y3ng~54cfb8583e7976f385567f4b12a914ed
Upcoming events on Edesa Biotech, Inc.
Past events on Edesa Biotech, Inc.
| 2024-04-17 11:00 am | Bloom Burton & Co. Healthcare Investor Conference |
| 2024-04-14 | Mintz Conference |
| 2024-03-27 | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference |
| 2024-03-17 | BioEurope Spring Conference |
| 2024-03-11 | Barclays Global Healthcare Conference |
| 2024-03-07 | American Academy of Dermatology Meeting |
| 2024-03-06 | American Contact Dermatitis Society Meeting |
| 2024-02-09 04:15 pm | Q1 2024 Earnings Release |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-12-15 04:10 pm | Q4 2023 Earnings Release |
| 2023-11-05 | Bio-Europe Conference |
| 2023-11-01 02:10 pm | Dermatology Drug Development Summit |
| 2023-09-10 | H.C. Wainwright Global Investment Conference |
| 2023-08-10 12:00 pm | Canaccord Genuity Growth Conference |
| 2023-08-09 04:15 pm | Q3 2023 Earnings Release |
| 2023-06-04 | BIO International Convention |
| 2023-05-23 10:30 am | Annual General Meeting |
| 2023-05-11 04:30 pm | Q2 2023 Earnings Release |
| 2023-04-23 | Swiss Biotech Day |
| 2023-03-29 | H.C. Wainwright Autoimmune & Inflammatory Disease Conference |
Annual results
| Fiscal Period | September | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,33 0,31 5.98% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -23,6 -12,0 -96.35% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,40 -6,54 2.12% | -23,7 -24,4 2.98% | -18,4 -21,9 16.12% | -9,22 -9,03 -2.11% | -9,13 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,36 -6,10 -4.32% | -13,3 -15,5 13.83% | -17,5 -20,9 15.84% | -8,37 -8,84 5.24% | -8,63 |
|
Net income Million USD | Released Forecast Spread | -6,36 -6,10 -4.33% | -13,3 -15,5 13.82% | -17,5 -20,9 15.83% | -8,37 -8,85 5.32% | -8,63 |
|
EPS USD | Released Forecast Spread | -5,18 -4,90 -5.71% | -7,70 -8,38 8.08% | -7,35 -10,0 26.83% | -2,93 -3,09 5.18% | -2,32 |
| Announcement Date | 07/12/20 | 28/12/21 | 16/12/22 | 15/12/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,16 -5,40 4.41% | -4,58 -5,44 15.9% | -5,80 -6,60 12.16% | -2,84 -6,40 55.68% | -2,38 -3,55 33.01% | -2,41 -3,32 27.32% | -2,06 -3,55 41.8% | -2,37 -2,13 -11.08% | -1,86 -3,80 51.12% | -2,25 | -2,32 | -2,68 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,38 -5,40 18.91% | -4,57 -5,27 13.35% | -5,79 -6,60 12.32% | -2,81 -6,15 54.25% | -2,33 -3,55 34.23% | -2,33 -3,31 29.54% | -1,98 -3,54 43.96% | -1,72 -2,13 19.17% | -1,68 -3,68 54.33% | -2,17 | -2,19 | -2,57 |
|
Net income Million USD | Released Forecast Spread | -4,38 -5,40 18.91% | -4,57 -5,27 13.33% | -5,79 -6,60 12.32% | -2,81 -6,15 54.25% | -2,33 -3,55 34.23% | -2,33 -3,31 29.51% | -1,98 -3,54 43.96% | -1,72 -2,13 19.17% | -1,68 -3,68 54.33% | -2,17 | -2,19 | -2,57 |
|
EPS USD | Released Forecast Spread | -2,31 -2,80 17.5% | -2,31 -2,57 10% | -2,59 -3,01 13.95% | -0,07 -2,77 97.47% | -0,91 -1,33 31.58% | -0,84 -1,21 30.77% | -0,70 -1,21 42.31% | -0,48 -0,72 32.87% | -0,54 -1,21 55.37% | -0,69 | -0,52 | -0,62 |
| Announcement Date | 14/02/22 | 13/05/22 | 12/08/22 | 16/12/22 | 10/02/23 | 11/05/23 | 09/08/23 | 15/12/23 | 09/02/24 | - | - | - |
More events
Past sector events for Edesa Biotech, Inc.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EDSA Stock
- Calendar Edesa Biotech, Inc.
